High-Dose Methotrexate: Is it Warranted?
- 1 January 1994
- journal article
- editorial
- Published by Informa UK Limited in Pediatric Hematology and Oncology
- Vol. 11 (2), 135-137
- https://doi.org/10.3109/08880019409141647
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Evaluation of Serious Adverse Events in Patients Treated with Protocols Including Methotrexate InfusionsPediatric Hematology and Oncology, 1994
- Back to the basics: the importance of concentration x time in oncology.Journal of Clinical Oncology, 1993
- Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.Journal of Clinical Oncology, 1993
- How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Letter tO the EditorBritish Journal of Cancer, 1989
- Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescueBritish Journal of Cancer, 1989
- High dose methotrexate therapy: Insecure rationale?Biochemical Pharmacology, 1988
- Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapyCancer, 1973
- Continuous infusion of methotrexate in children with acute leukemiaCancer, 1967
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948